(Q40961292)

25 September 2017

1 reference

title

Cyclosporin. A review of the pharmacokinetic properties, clinical efficacy and tolerability of a microemulsion-based formulation (Neoral). (English)

1 reference

25 September 2017

1 reference

2

A Markham

0 references

author name string

S Noble

series ordinal

1

1 reference

PubMed ID

8586033

25 September 2017

A Markham

series ordinal

2

1 reference

25 September 2017

1 November 1995

1 reference

25 September 2017

1 reference

25 September 2017

50

1 reference

25 September 2017

924-941

1 reference

25 September 2017

5

1 reference

https://scigraph.springernature.com/pub.10.2165/00003495-199550050-00009

25 September 2017

0 references

cites work

Enhanced bioavailability of cyclosporine using a new oral formulation (Sandimmun optoral) in a liver-grafted patient with severe cholestasis

1 reference

12 December 2020

Individualization of cyclosporine therapy using pharmacokinetic and pharmacodynamic parameters

1 reference

12 December 2020

Assessment of glomerular filtration rate after multiple administration of a new oral formulation of cyclosporine in clinically stable renal transplant patients

1 reference

12 December 2020

A double-blind randomized study of Sandimmun Neoral versus Sandimmun in new renal transplant recipients: results after 12 months. The International Sandimmun Neoral Study Group

1 reference

12 December 2020

Consensus document: Hawk's Cay meeting on therapeutic drug monitoring of cyclosporine

1 reference

12 December 2020

Reduced inter- and intraindividual variability in cyclosporine pharmacokinetics from a microemulsion formulation

1 reference

12 December 2020

Cyclosporine: mechanisms of action and toxicity.

1 reference

12 December 2020

Influence of a fat-rich meal on the pharmacokinetics of a new oral formulation of cyclosporine in a crossover comparison with the market formulation.

1 reference

12 December 2020

Preliminary pharmacokinetic evaluation of a new galenical formulation of oral cyclosporine A: Neoral TM

1 reference

12 December 2020

Sandimmune Neoral in paediatric liver transplant recipients with malabsorption of cyclosporin A

1 reference

12 December 2020

Potential for CsA-Neoral in organ transplantation

1 reference

12 December 2020

Improved dose linearity of cyclosporine pharmacokinetics from a microemulsion formulation

1 reference

12 December 2020

Rationale for the development of Sandimmune Neoral

1 reference

12 December 2020

Pharmacokinetics and tolerability of a microemulsion formulation of cyclosporine in renal allograft recipients--a concentration-controlled comparison with the commercial formulation

1 reference

12 December 2020

Use of Sandimmun Neoral in renal transplant patients. International Sandimmun Neoral Study Group.

1 reference

12 December 2020

Demographic factors influencing cyclosporine pharmacokinetic parameters in patients with uremia: racial differences in bioavailability

1 reference

12 December 2020

Reduced inter- and intrasubject variability in cyclosporine pharmacokinetics in renal transplant recipients treated with a microemulsion formulation in conjunction with fasting, low-fat meals, or high-fat meals.

1 reference

12 December 2020

Cyclosporin. A review of its pharmacodynamic and pharmacokinetic properties, and therapeutic use in immunoregulatory disorders

1 reference

12 December 2020

Pharmacokinetics of a new galenical formulation of oral cyclosporine A in stable kidney transplanted patients

1 reference

12 December 2020

Relative bioavailability of Sandimmune and Sandimmune Neoral in pediatric liver recipients

1 reference

12 December 2020

Immunopharmacological monitoring of cyclosporin A-treated recipients of cadaveric kidney allografts

1 reference

12 December 2020

Comparison of the pharmacokinetics of cyclosporine Sandimmune with Sandimmune Neoral in stable renal transplant patients

1 reference

12 December 2020

Relative bioavailability of a new oral form of cyclosporin A in patients with rheumatoid arthritis

1 reference

12 December 2020

Optimization of cyclosporine therapy in renal transplantation by a pharmacokinetic strategy

1 reference

12 December 2020

Cyclosporine levels in diabetic (type 1) patients undergoing kidney and pancreas transplantation: role of a new galenica formulation

1 reference

12 December 2020

Cyclosporine pharmacokinetics and variability from a microemulsion formulation--a multicenter investigation in kidney transplant patients

1 reference

12 December 2020

Pharmacokinetics of a new oral formulation of cyclosporine in liver transplant recipients.

1 reference

12 December 2020

Hyperlipidemia and glucose intolerance in the post-renal transplant patient

1 reference

12 December 2020

Cyclosporine Neoral in liver transplant recipients

1 reference

12 December 2020

Clinical experience transferring kidney transplant patients from Sandimmun to Sandimmun Neoral--results after 3 months.

1 reference

12 December 2020

Within-day consistency in cyclosporine pharmacokinetics from a microemulsion formulation in renal transplant patients.

1 reference

12 December 2020

Sandimmun-Neoral in liver transplantation: a remarkable improvement in long-term immunosuppression

1 reference

12 December 2020

Pharmacokinetic profile of cyclosporine in long-term heart transplanted patients treated with a new oral formulation

1 reference

12 December 2020

Cyclosporin clinical pharmacokinetics

1 reference

12 December 2020

Bile-independent absorption of cyclosporine from a microemulsion formulation in liver transplant patients

1 reference

12 December 2020

Cyclosporine neoral in liver transplant recipients.

1 reference

12 December 2020

Influence of cyclosporine pharmacokinetics, trough concentrations, and AUC monitoring on outcome after kidney transplantation.

1 reference

12 December 2020

Diagnostic utility of whole blood cyclosporine measurements in renal transplantation using triple therapy

1 reference

12 December 2020

Conversion from Sandimmun to Sandimmun Neoral in patients with stable renal allografts: results after 1 month

1 reference

12 December 2020

Absorption of cyclosporin from conventional and new microemulsion oral formulations in liver transplant recipients with external biliary diversion

1 reference

12 December 2020

Neoral in liver transplant patients: pharmacokinetic study and clinical implications.

1 reference

12 December 2020

Relative bioavailability of cyclosporin from conventional and microemulsion formulations in heart-lung transplant candidates with cystic fibrosis

1 reference

12 December 2020

Prevention and management of the adverse effects associated with immunosuppressive therapy

1 reference

12 December 2020

Influence of bile on cyclosporin absorption from microemulsion formulation in primary liver transplant recipients

1 reference

12 December 2020

Comparison of pharmacokinetics between CsA capsules and Sandimmun Neoral in pediatric patients

1 reference

12 December 2020

Favourable clinical results of Sandimmun-Neoral in malabsorbing liver and heart transplant recipients

1 reference

12 December 2020

Cyclosporine disposition and metabolite profiles in renal transplant patients receiving a microemulsion formulation

1 reference

12 December 2020

Small-bowel length and the dose of cyclosporine in children after liver transplantation

1 reference

12 December 2020

Use of Neoral in heart transplant recipients

1 reference

12 December 2020

Economic analysis of Sandimmune Neoral in Canada in stable renal transplant patients

1 reference

12 December 2020

10.2165/00003495-199550050-00009

Identifiers

DOI

1 reference

PubMed ID

8586033

Dimensions Publication ID

25 September 2017

0 references

1 reference

PubMed ID

8586033